fludarabine phosphate [clinicaltrials_resource:3eca53a644472ef37f5113452bce55b2]
Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia [clinicaltrials:NCT00003248]Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [clinicaltrials:NCT00003619]Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia [clinicaltrials:NCT00003729]Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00003764]Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00004114]Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease [clinicaltrials:NCT00004194]Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia [clinicaltrials:NCT00004218]Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma [clinicaltrials:NCT00005580]Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia [clinicaltrials:NCT00005802]Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00005863]Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer [clinicaltrials:NCT00005941]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma [clinicaltrials:NCT00006100]Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery [clinicaltrials:NCT00006126]Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00006233]Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma [clinicaltrials:NCT00006250]Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00008151]Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [clinicaltrials:NCT00008307]Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00014508]Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia [clinicaltrials:NCT00017108]UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia [clinicaltrials:NCT00019838]Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer [clinicaltrials:NCT00020176]Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia [clinicaltrials:NCT00020800]Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [clinicaltrials:NCT00024440]Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer [clinicaltrials:NCT00025519]Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00027547]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00027924]Comparison of Fludarabine Plus Total-Body Irradiation With Combination Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00041288]Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00044954]Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma [clinicaltrials:NCT00045513]Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00049075]Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma [clinicaltrials:NCT00053092]Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [clinicaltrials:NCT00055653]Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00056095]Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00062036]Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00066300]Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia [clinicaltrials:NCT00066417]Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation [clinicaltrials:NCT00073879]
intervention [clinicaltrials_vocabulary:intervention]
fludarabine phosphate [clinicaltrials_resource:3eca53a644472ef37f5113452bce55b2]
Bio2RDF identifier
3eca53a644472ef37f5113452bce55b2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3eca53a644472ef37f5113452bce55b2
intervention name [clinicaltrials_vocabulary:intervention-name]
fludarabine phosphate
identifier
clinicaltrials_resource:3eca53a644472ef37f5113452bce55b2
title
fludarabine phosphate
@en
type
label
fludarabine phosphate [clinicaltrials_resource:3eca53a644472ef37f5113452bce55b2]
@en